
Cosmo First Reports Q4, FY25 and FY24-25 Results with 11% Q4 EBITDA and 13% FY25 EBITDA
Cosmo First Limited has declared its financial results for the quarter and year ended March 2025. Q4 FY25 EBITDA is backed by higher specialty sales and better BOPP & BOPET film margins. The EBITDA would have been better but for one-time non-recurring cost of Rs 4.3 crores and 10% lower volume of BOPET film due to planned shutdown. FY25 EBITDA is higher primarily due to higher specialty sales (10% growth vs PY), cost rationalization of about Rs 25 crores, better BOPP and BOPET films margins and improved performance of specialty chemical subsidiary. The Company has invested 1,180 crores in the last 3 years in multiple growth projects which will yield a significant ramp up in revenue and profitability in the next 2 to 3 years. Cosmo First has successfully done pilot runs with 50+ distributors for Sunshield films and Paint Protection films. The BOPP line having annual capacity of 81k Mt p.a. is also expected to start operations from Q1, FY26. The Specialty Chemical subsidiary has achieved high teens EBITDA with topline of Rs 180 crores in FY25. The Board of Directors had recommended dividend of Rs.4 per equity share for the financial year FY 24-25.
Key Highlights
- Q4 FY25 EBITDA is 11% with higher specialty sales and better BOPP & BOPET film margins.
- FY25 EBITDA is 13% higher primarily due to higher specialty sales, cost rationalization, better BOPP and BOPET films margins and improved performance of specialty chemical subsidiary.
- Cosmo First has invested 1,180 crores in the last 3 years in multiple growth projects.
- Successfully done pilot runs with 50+ distributors for Sunshield films and Paint Protection films.
- The Specialty Chemical subsidiary has achieved high teens EBITDA with topline of Rs 180 crores in FY25.